FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

22224911000001109: Gliclazide 60mg modified-release tablets 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
73440901000001116 Gliclazide 60mg modified-release tablets 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
73441001000001113 Gliclazide 60mg modified-release tablets 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

9 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gliclazide 60mg modified-release tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Gliclazide 60mg modified-release tablets 28 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Gliclazide 60mg modified-release tablets 28 tablet Has VMP Gliclazide 60mg modified-release tablets true Inferred relationship Existential restriction modifier
Gliclazide 60mg modified-release tablets 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Gliclazide 60mg modified-release tablets 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Gliclazide 60mg modified-release tablets 28 tablet Has specific active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Gliclazide 60mg modified-release tablets 28 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Gliclazide 60mg modified-release tablets (DE Pharmaceuticals) 28 tablet Is a True Gliclazide 60mg modified-release tablets 28 tablet Inferred relationship Existential restriction modifier
Bilxona 60mg modified-release tablets (Accord Healthcare Ltd) 28 tablet 2 x 14 tablets Is a True Gliclazide 60mg modified-release tablets 28 tablet Inferred relationship Existential restriction modifier
Gliclazide 60mg modified-release tablets (Krka UK Ltd) 28 tablet 2 x 14 tablets Is a True Gliclazide 60mg modified-release tablets 28 tablet Inferred relationship Existential restriction modifier
Lamzarin 60mg modified-release tablets (Key Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Is a True Gliclazide 60mg modified-release tablets 28 tablet Inferred relationship Existential restriction modifier
Gliclazide 60mg modified-release tablets (A A H Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Is a True Gliclazide 60mg modified-release tablets 28 tablet Inferred relationship Existential restriction modifier
Gliclazide 60mg modified-release tablets (Accord Healthcare Ltd) 28 tablet 2 x 14 tablets Is a True Gliclazide 60mg modified-release tablets 28 tablet Inferred relationship Existential restriction modifier
Laaglyda MR 60mg tablets (Krka UK Ltd) 28 tablet 2 x 14 tablets Is a True Gliclazide 60mg modified-release tablets 28 tablet Inferred relationship Existential restriction modifier
Vamju 60mg modified-release tablets (AMCo) 28 tablet 2 x 14 tablets Is a True Gliclazide 60mg modified-release tablets 28 tablet Inferred relationship Existential restriction modifier
Bilxona 60mg modified-release tablets (Actavis UK Ltd) 28 tablet 2 x 14 tablets Is a True Gliclazide 60mg modified-release tablets 28 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start